laboratory services, namely, drawing blood for testing purposes; laboratory testing services; clinical laboratory services; medical laboratory services; scientific laboratory services; laboratory services, namely, testing blood for patient triage or risk stratification purposes, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients; laboratory services, namely, gene and protein testing; laboratory research and development, validation testing, and data analysis in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; laboratory services, namely, providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; laboratory services, namely, compiling and providing access to databases of life sciences information via global, national and local computer networks in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; laboratory services, namely, evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research; and laboratory research services, namely, researching and developing the use of biomarkers as indicators or predictors of body state, including body health, condition, disease, or response to therapeutic treatment

Medical laboratory services; scientific laboratory services; laboratory services, namely, gene and protein testing; laboratory research and development, validation testing, and data analysis in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics; laboratory services, namely, providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; laboratory services, namely, compiling and providing access to databases of life sciences information via global, national and local computer networks in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; laboratory services, namely, evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research; and laboratory research services, namely, researching and developing the use of biomarkers as indicators or predictors of body state, including body health, condition, disease, or response to therapeutic treatment

Medical testing for diagnostic or treatment services, namely, drawing blood for testing purposes, and testing blood for patient triage or risk stratification purposes, and determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients